Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid vs misoprostol vs oxytocin to reduce post‑cesarean hemorrhage
IRCT201708308611N6Phase 3Completed
- Sponsor
- Vice-Chancellor for Research of Qazvin University of Medical Sciences
- Start
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postpartum hemorrhage (PPH) comparing Intravenous tranexamic acid, Sublingual misoprostol and Oxytocin (3 arms). Primary endpoint: Reduction in post‑cesarean hemorrhage. Started Jan 2017; status: completed.
02
Drugs
tranexamic acidmisoprostoloxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT201708308611N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201708308611N6.